Skip to content
Nuclear medicine
About us
Close About us
Open About us
Position Papers
Members
Working Groups
Close Working Groups
Open Working Groups
Activities
Close Activities
Open Activities
News
Publications
Activity Reports
EU Affairs
Symposium
Contact
Nuclear medicine
About Us
Members
Working Groups
Activities
Contact
Activity Reports
Publications
News
EU Affairs
Symposium
About Us
Position Papers
Member login
Home
»
Activities
»
News
News
Nuclear Medicine Europe’s major updates
Understanding Radiation Protection in Radioligand Therapy
PRESS RELEASE : the European Nuclear Medicine Day
Introducing the European Nuclear Medicine Day event in Brussels
Economist World Cancer Series Europe 2026 – event report
Reimagining Europe’s health systems Summit 2026
Nuclear Medicine Europe announces new leadership for Security of Supply and Therapy Working Groups
European Commission Biotech Act Proposed Nuclear Medicine Europe amendments for radiopharmaceuticals
EMA Recognizes Radiopharmaceuticals as Priority Area in New Report
Nuclear Medicine Europe Brings the Voice of the Industry to EANM’s Personalised Theranostics Forum
Dosimetry in context of Therapeutic Radiopharmaceuticals
Interview-based series entitled : “Beyond Imaging: Nuclear Medicine’s Next Decade”
Interview with Dr. Paulien Moyaert: Leveraging digital media to demystify nuclear medicine
Integrating Nuclear Medicine Europe into the Framework of the Critical Medicines Alliance
The revolution in nuclear medicine in the 21st century
Science, Significance, and Future Perspectives Of Nuclear Medicine Dialogue with a nuclear medicine specialist
Why do medical students decide not to get trained in the most appealing speciality, nuclear medicine?
How does nuclear medicine saves lives
Updated: Nuclear Medicine Europe Hygieia posters
Position Paper: What is nuclear medicine & how can it help Europe beat cancer?
Artificial Intelligence in Nuclear Medicine
How the Nuclear Medicine Sector Coordinates Isotope Supply
How the COVID crisis has affected the transport of radiopharmaceuticals
Diagnosis Tracers and Radiotherapeutics – What For?
Activity Report: Nuclear Medicine Europe Newsletter 2019-2022
How nuclear medicine patient care continues in the COVID era
Nuclear Medicine From status quo to status go
Cyclotrons for Medical Radionuclide Production
The 2025–2028 Executive Committee of Nuclear Medicine Europe
2025 Annual General Assembly Evening Dinner
Communicating nuclear medicine to a wider audience
Election of Working Groups new Co-Chairs
Official Statement from Nuclear Medicine Europe and the Transport Experts Working Group
Nuclear Medicine Europe launches the interactive Hygieia
Publication : Science, Significance, and Future Perspectives Of Nuclear Medicine
Jan Schöpflin (Eckert & Ziegler) Elected as New Co-Chair of the Nuclear Medicine Europe Communications Working Group
Nuclear Medicine Advocacy in European Legislation
Position paper on the Ban on Lead for the Transport of Radiopharmaceuticals
Restart Delay of the HFR Reactor
Delay in Return to Service of Maria Research Reactor (Poland)
Nuclear Medicine Europe Position Paper
Nuclear Medicine Europe 2019-2022 Newsletter
Nuclear Medicine Europe Executive Committee
Parliament’s backing for nuclear medicine is huge boost for sector
How the nuclear medicine sector coordinates isotope supply
Why MEPs need to back Fiocchi’s amendments to the cancer report
Whatisnuclearmedicine.com update
Summary of the 2021 Nuclear Medicine Europe Symposium
2021 Nuclear Medicine Europe Symposium
Lifesaving nuclear medicine applications deserve better recognition and support at EU level
COVID and the transport of radiopharmaceuticals
Staying safe, saving life
From status quo to status go
